novel and orally bioavailable inducible nitric oxide synthase inhibitors. synthesis and evaluation...

1
2005 Organo-selenium compounds Organo-selenium compounds S 0130 Novel and Orally Bioavailable Inducible Nitric Oxide Synthase Inhibitors. Syn- thesis and Evaluation of Optically Active 4,5-Dialkyl-2-iminoselenazolidine De- rivatives. — A series of novel optically active 4,5-dialkyl-2-iminoselenazolidine de- rivatives (VII) and (VIII) is synthesized by two synthetic methods. The pathway via the chromatographic separation of the isomers (V) and (VI) is also used for the synthesis of the enantiomers of (VII) and (VIII). All compounds are examined for their in vitro and in vivo inhibitory activity against iNOS. (VII) shows the best selectivity for iNOS and strong inhibitory activity. — (UEDA*, S.; TERAUCHI, H.; SUZUKI, K.; YANO, A.; MATSUMOTO, M.; KUBO, T.; MINATO, H.; ARAI, Y.; TSUJI, J.-I.; WATANABE, N.; Bioorg. Med. Chem. Lett. 15 (2005) 5, 1361-1366; Chem. Res. Lab., Dainippon Pharm. Co., Ltd., Suita, Osaka 564, Japan; Eng.) — H. Haber 28- 185

Upload: shigeo-ueda

Post on 06-Jun-2016

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Novel and Orally Bioavailable Inducible Nitric Oxide Synthase Inhibitors. Synthesis and Evaluation of Optically Active 4,5-Dialkyl-2-iminoselenazolidine Derivatives

2005 Organo-selenium compounds

Organo-selenium compoundsS 0130 Novel and Orally Bioavailable Inducible Nitric Oxide Synthase Inhibitors. Syn-

thesis and Evaluation of Optically Active 4,5-Dialkyl-2-iminoselenazolidine De-rivatives. — A series of novel optically active 4,5-dialkyl-2-iminoselenazolidine de-rivatives (VII) and (VIII) is synthesized by two synthetic methods. The pathway via the chromatographic separation of the isomers (V) and (VI) is also used for the synthesis of the enantiomers of (VII) and (VIII). All compounds are examined for their in vitro and in vivo inhibitory activity against iNOS. (VII) shows the best selectivity for iNOS and strong inhibitory activity. — (UEDA*, S.; TERAUCHI, H.; SUZUKI, K.; YANO, A.; MATSUMOTO, M.; KUBO, T.; MINATO, H.; ARAI, Y.; TSUJI, J.-I.; WATANABE, N.; Bioorg. Med. Chem. Lett. 15 (2005) 5, 1361-1366; Chem. Res. Lab., Dainippon Pharm. Co., Ltd., Suita, Osaka 564, Japan; Eng.) — H. Haber

28- 185